Switching Breast Cancer Patients with Progressive Bone Metastases to Third-Generation Bisphosphonates: Measuring Impact Using the Functional Assessment of Cancer Therapy-Bone Pain

Reuben Broom, Hongyan Du, Mark Clemons, David Eton, George Dranitsaris, Christine Simmons, Wei Ooi, David Cella*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

43 Scopus citations

Fingerprint

Dive into the research topics of 'Switching Breast Cancer Patients with Progressive Bone Metastases to Third-Generation Bisphosphonates: Measuring Impact Using the Functional Assessment of Cancer Therapy-Bone Pain'. Together they form a unique fingerprint.

Medicine & Life Sciences